- Home
- SAGE vs RBB Comparison
SAGE vs RBB Comparison
Compare SAGE & RBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- RBB
- Stock Information
- Founded
- SAGE 2010
- RBB 2008
- Country
- SAGE United States
- RBB United States
- Employees
- SAGE N/A
- RBB N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- RBB Major Banks
- Sector
- SAGE Health Care
- RBB Finance
- Exchange
- SAGE Nasdaq
- RBB Nasdaq
- Market Cap
- SAGE 462.2M
- RBB 410.1M
- IPO Year
- SAGE 2014
- RBB 2017
- Fundamental
- Price
- SAGE $5.61
- RBB $21.32
- Analyst Decision
- SAGE Hold
- RBB Hold
- Analyst Count
- SAGE 19
- RBB 4
- Target Price
- SAGE $11.53
- RBB $20.88
- AVG Volume (30 Days)
- SAGE 1.1M
- RBB 41.9K
- Earning Date
- SAGE 02-12-2025
- RBB 01-21-2025
- Dividend Yield
- SAGE N/A
- RBB 3.00%
- EPS Growth
- SAGE N/A
- RBB N/A
- EPS
- SAGE N/A
- RBB 1.87
- Revenue
- SAGE $106,399,000.00
- RBB $115,630,000.00
- Revenue This Year
- SAGE N/A
- RBB N/A
- Revenue Next Year
- SAGE $122.78
- RBB $7.13
- P/E Ratio
- SAGE N/A
- RBB $11.43
- Revenue Growth
- SAGE 837.60
- RBB N/A
- 52 Week Low
- SAGE $4.62
- RBB $16.49
- 52 Week High
- SAGE $28.26
- RBB $25.30
- Technical
- Relative Strength Index (RSI)
- SAGE 50.27
- RBB 27.87
- Support Level
- SAGE $4.94
- RBB $22.95
- Resistance Level
- SAGE $5.91
- RBB $23.50
- Average True Range (ATR)
- SAGE 0.36
- RBB 0.67
- MACD
- SAGE 0.02
- RBB -0.29
- Stochastic Oscillator
- SAGE 69.07
- RBB 8.66
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About RBB RBB Bancorp
RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.